ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,516 | -8.1% | 176,700 | 0.0% | 0.00% | – |
| Q2 2023 | $284,487 | -17.5% | 176,700 | +48.7% | 0.00% | – |
| Q1 2023 | $344,636 | -12.2% | 118,840 | -0.7% | 0.00% | – |
| Q4 2022 | $392,419 | -3.1% | 119,640 | +11.8% | 0.00% | – |
| Q3 2022 | $405,000 | -30.3% | 107,040 | +43.4% | 0.00% | – |
| Q2 2022 | $581,000 | -15.3% | 74,640 | +1.1% | 0.00% | – |
| Q1 2022 | $686,000 | -40.9% | 73,840 | +0.3% | 0.00% | – |
| Q4 2021 | $1,161,000 | -13.9% | 73,640 | -2.3% | 0.00% | -100.0% |
| Q3 2021 | $1,349,000 | +6.9% | 75,340 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $1,262,000 | +8.3% | 81,140 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,165,000 | -24.6% | 81,140 | +3.0% | 0.00% | 0.0% |
| Q4 2020 | $1,546,000 | +51.6% | 78,740 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,020,000 | +0.7% | 78,740 | +13.2% | 0.00% | 0.0% |
| Q2 2020 | $1,013,000 | +89.0% | 69,540 | +10.5% | 0.00% | – |
| Q1 2020 | $536,000 | -40.4% | 62,940 | +15.2% | 0.00% | -100.0% |
| Q4 2019 | $900,000 | +16.6% | 54,640 | 0.0% | 0.00% | – |
| Q3 2019 | $772,000 | -29.8% | 54,640 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $1,099,000 | -49.4% | 54,640 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,172,000 | +14.4% | 54,640 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,898,000 | -16.0% | 54,640 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,259,000 | +12.5% | 54,640 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,008,000 | +78.5% | 54,640 | +89.5% | 0.00% | 0.0% |
| Q1 2018 | $1,125,000 | +124.1% | 28,840 | +4.0% | 0.00% | – |
| Q4 2017 | $502,000 | +9.4% | 27,740 | 0.0% | 0.00% | – |
| Q3 2017 | $459,000 | +18.3% | 27,740 | 0.0% | 0.00% | – |
| Q2 2017 | $388,000 | +1.8% | 27,740 | +49.6% | 0.00% | – |
| Q1 2017 | $381,000 | +27.4% | 18,540 | -11.9% | 0.00% | – |
| Q4 2016 | $299,000 | -33.6% | 21,040 | 0.0% | 0.00% | – |
| Q3 2016 | $450,000 | -12.8% | 21,040 | -8.3% | 0.00% | – |
| Q2 2016 | $516,000 | +45.4% | 22,940 | +23.1% | 0.00% | – |
| Q1 2016 | $355,000 | -37.3% | 18,640 | -13.1% | 0.00% | – |
| Q4 2015 | $566,000 | -16.0% | 21,440 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $674,000 | -40.6% | 21,440 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $1,134,000 | +346.5% | 21,500 | +252.5% | 0.00% | – |
| Q1 2015 | $254,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |